Showing results (211-220 of 315) with videos related to

Sort By:
Pageof 32
Indian Pediatrics|February 2, 2015
Revised IAP growth charts for height, weight and body mass index for 5- to 18-year-old Indian children, Vaman Khadilkar, Sangeeta Yadav, et al.
The Plant Cell|September 17, 2013
Temporal-spatial interaction between reactive oxygen species and abscisic acid regulates rapid systemic acclimation in plantsNobuhiro Suzuki, Gad Miller, Carolina Salazar, et al.
British Journal of Cancer|July 1, 2010
A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European regionP A Cassier, F Ducimetière, A Lurkin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 2, 2013
Correlation between overall survival and growth modulation index in pre-treated sarcoma patients: a study from the French Sarcoma GroupS Cousin, J Y Blay, F Bertucci, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2004
Conformity to clinical practice guidelines, multidisciplinary management and outcome of treatment for soft tissue sarcomasI Ray-Coquard, P Thiesse, D Ranchère-Vince, et al.
Mymensingh Medical Journal : MMJ|September 3, 2014
Stroke in Bangladeshi patients and risk factorQ D Mohammad, M Habib, B A Mondal, et al.
British Journal of Cancer|October 10, 2007
Intensified dose of cyclophosphamide with G-CSF support versus standard dose combined with platinum in first-line treatment of advanced ovarian cancer a randomised study from the GINECO groupI Ray-Coquard, D Paraiso, J-P Guastalla, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 1, 2013
Adherence to treatment guidelines for primary sarcomas affects patient survival: a side study of the European CONnective TIssue CAncer NETwork (CONTICANET)C R Rossi, A Vecchiato, G Mastrangelo, et al.
Bulletin Du Cancer|May 28, 2010
[Incidence rate, epidemiology of sarcoma and molecular biology. Preliminary results from EMS study in the Rhône-Alpes region]F Ducimetière, A Lurkin, D Ranchère-Vince, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 24, 2012
Influence of imatinib interruption and rechallenge on the residual disease in patients with advanced GIST: results of the BFR14 prospective French Sarcoma Group randomised, phase III trialA Patrikidou, S Chabaud, I Ray-Coquard, et al.
Pageof 32